Histogram
Visit number vs Creatinine, Urine
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 49 | 127.1 | ± 75.6 | 116.2 | 15.2 | 311.4 | - | 49 |
9-Month Followup | 43 | 150.2 | ± 92.9 | 130.1 | 31.3 | 434.2 | - | 43 |
18-Month Followup | 40 | 150.6 | ± 95.5 | 135.8 | 18.4 | 371.8 | - | 40 |
Randomized treatment arm vs Creatinine, Urine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 127.1 | ± 75.6 | 116.2 | 15.2 | 311.4 | - | 49 |
Laparoscopic Gastric Banding (LGB) | 28 | 120.0 | ± 74.9 | 102.1 | 15.2 | 311.4 | - | 28 |
Continuous Positive Airway Pressure (CPAP) | 21 | 136.6 | ± 77.2 | 135.0 | 33.5 | 287.7 | - | 21 |
Randomized treatment arm vs Creatinine, Urine
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 150.2 | ± 92.9 | 130.1 | 31.3 | 434.2 | - | 43 |
Laparoscopic Gastric Banding (LGB) | 25 | 137.0 | ± 92.7 | 127.4 | 31.3 | 434.2 | - | 25 |
Continuous Positive Airway Pressure (CPAP) | 18 | 168.6 | ± 92.7 | 138.3 | 60.9 | 394.4 | - | 18 |
Randomized treatment arm vs Creatinine, Urine
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 150.6 | ± 95.5 | 135.8 | 18.4 | 371.8 | - | 40 |
Laparoscopic Gastric Banding (LGB) | 24 | 143.5 | ± 100.7 | 128.5 | 18.4 | 370.5 | - | 24 |
Continuous Positive Airway Pressure (CPAP) | 16 | 161.2 | ± 89.3 | 145.0 | 43.7 | 371.8 | - | 16 |
Age of the participant vs Creatinine, Urine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 127.1 | ± 75.6 | 116.2 | 15.2 | 311.4 | - | 49 |
27.0 to 45.0 years | 13 | 158.7 | ± 70.1 | 156.9 | 33.5 | 287.7 | - | 13 |
46.0 to 50.0 years | 12 | 127.2 | ± 70.7 | 125.0 | 36.9 | 229.7 | - | 12 |
51.0 to 56.0 years | 12 | 131.7 | ± 77.1 | 122.3 | 49.4 | 286.8 | - | 12 |
57.0 to 65.0 years | 12 | 88.2 | ± 75.8 | 72.5 | 15.2 | 311.4 | - | 12 |
Age of the participant vs Creatinine, Urine
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 150.2 | ± 92.9 | 130.1 | 31.3 | 434.2 | - | 43 |
28.0 to 47.0 years | 11 | 152.4 | ± 80.3 | 127.4 | 78.5 | 321.4 | - | 11 |
47.0 to 52.0 years | 11 | 147.3 | ± 74.9 | 140.1 | 31.3 | 279.3 | - | 11 |
52.0 to 58.0 years | 11 | 176.3 | ± 122.8 | 131.5 | 48.3 | 434.2 | - | 11 |
58.0 to 65.0 years | 10 | 122.3 | ± 91.8 | 81.9 | 56.4 | 331.8 | - | 10 |
Age of the participant vs Creatinine, Urine
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 150.6 | ± 95.5 | 135.8 | 18.4 | 371.8 | - | 40 |
29.0 to 46.0 years | 10 | 170.4 | ± 90.3 | 146.5 | 81.9 | 371.8 | - | 10 |
47.0 to 52.0 years | 10 | 150.8 | ± 83.2 | 146.7 | 25.5 | 295.3 | - | 10 |
53.0 to 58.0 years | 10 | 126.0 | ± 82.2 | 119.0 | 31.2 | 273.2 | - | 10 |
58.0 to 65.0 years | 10 | 155.0 | ± 128.7 | 89.4 | 18.4 | 370.5 | - | 10 |
Gender of the participant vs Creatinine, Urine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 49 | 127.1 | ± 75.6 | 116.2 | 15.2 | 311.4 | - | 49 |
Male | 28 | 158.6 | ± 73.4 | 154.5 | 39.1 | 311.4 | - | 28 |
Female | 21 | 85.2 | ± 56.5 | 77.6 | 15.2 | 273.1 | - | 21 |
Gender of the participant vs Creatinine, Urine
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 43 | 150.2 | ± 92.9 | 130.1 | 31.3 | 434.2 | - | 43 |
Male | 25 | 182.3 | ± 101.8 | 151.5 | 31.3 | 434.2 | - | 25 |
Female | 18 | 105.7 | ± 55.7 | 103.9 | 48.3 | 279.3 | - | 18 |
Gender of the participant vs Creatinine, Urine
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 150.6 | ± 95.5 | 135.8 | 18.4 | 371.8 | - | 40 |
Male | 25 | 180.7 | ± 95.7 | 155.6 | 49.0 | 371.8 | - | 25 |
Female | 15 | 100.3 | ± 73.3 | 81.9 | 18.4 | 278.1 | - | 15 |
Race of the participant vs Creatinine, Urine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 46 | 125.2 | ± 73.7 | 115.5 | 15.2 | 311.4 | - | 46 |
white | 35 | 116.2 | ± 61.9 | 114.8 | 33.5 | 286.8 | - | 35 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 9 | 143.5 | ± 106.5 | 89.3 | 15.2 | 311.4 | - | 9 |
asian | 2 | 199.8 | ± 78.5 | 199.8 | 144.3 | 255.3 | - | 2 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Creatinine, Urine
9-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 40 | 147.7 | ± 91.9 | 128.8 | 31.3 | 434.2 | - | 40 |
white | 31 | 145.8 | ± 96.3 | 127.4 | 31.3 | 434.2 | - | 31 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 8 | 162.2 | ± 81.2 | 159.4 | 56.4 | 331.8 | - | 8 |
asian | 1 | 90.1 | - | 90.1 | 90.1 | 90.1 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Creatinine, Urine
18-Month Followup
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 37 | 147.3 | ± 98.1 | 124.0 | 18.4 | 371.8 | - | 37 |
white | 29 | 136.9 | ± 96.6 | 105.9 | 18.4 | 371.8 | - | 29 |
american indian or alaska native | - | - | - | - | - | - | - | - |
black or african american | 7 | 191.5 | ± 106.8 | 155.6 | 73.0 | 370.5 | - | 7 |
asian | 1 | 138.6 | - | 138.6 | 138.6 | 138.6 | - | 1 |
native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
other | - | - | - | - | - | - | - | - |
multiple | - | - | - | - | - | - | - | - |